ABOUT SAFEMED INNOVATIONS

Empowering Safer Healthcare, One Solution at a Time

Safemed Innovations is an innovative and forward-thinking leader in the Philippine healthcare technology sector, passionately committed to transforming patient care and operational efficiency through the strategic integration of cutting-edge Artificial Intelligence (AI). Our mission extends beyond mere distribution; we are an innovation partner, guiding our clients through the complexities of digital transformation with forward-thinking solutions.

Medical
Facilitation

SafeMed Innovations Ventures Corporation is the exclusive partner of BioV Global in the Philippines, a global leader in cellular and molecular therapeutics. This unique relationship grants us privileged access to the highest-grade regenerative products, ensuring your treatment is powered by the most advanced science available.

P2 Stem Cells

BioV Global’ s P2 stem cells are a superior, highly potent form of Wharton ‘ s Jelly mesenchymal stem cells (WJ- MSCs) that have a higher proliferation capacity and a more robust growth pattern. This ensures a more potent and effective therapy compared to cells that have undergone more passages or divisions.

Exosomes

BioV Global’ s P2 stem cells are a superior, highly potent form of Wharton ‘ s Jelly mesenchymal stem cells (WJ- MSCs) that have a higher proliferation capacity and a more robust growth pattern. This ensures a more potent and effective therapy compared to cells that have undergone more passages or divisions.

SafeMed Cellular Program

Safemed Innovations Safemed Cellular Program in Partnership with BIO-V Global is a Game Changer

The SafeMed Cellular Program utilizes next-generation stem cell technology to offer highly effective, safe, and targeted treatments. We specialize in using Wharton ‘ s Jelly Mesenchymal Stem Cells (MSCs) from umbilical tissue , carefully selected from stringent donor criteria. These MSCs are harvested at passage 2 , ensuring the highest quality and therapeutic efficacy.

Our stem cell-based treatments focus on:

  •  Anti-aging treatments: Targeting cellular rejuvenation to slow down the aging process and restore vitality.
  • Chronic conditions: Addressing diabetes, liver and kidney problems, cardiovascular issues, and more with advanced regenerative solutions.
  • Our approach guarantees the potential for long-term, sustainable health improvements for those suffering from degenerative conditions.

Frequently Asked Questions

A: Our source is rightfully obtained, with the full consent of the donor or the baby’s parents. Donors and family members undergo rigorous health and genetic screening to ensure the cells are free from cancer, infectious diseases, and mutation.

A: MSC at Passage 2 (P2) are considered to be the highest quality for therapeutic due to their high functionality and stability, making them superior to cells from later passages for therapeutic.

A: Our laboratory will provide Certificate Of Analysis for MSC, and the quality of the MSC will be checked under our stringent quality control procedure, which involves the testing of the purity to ensure that all our products are of the highest standard.

A: The effectiveness varies depending on the overall health and condition of the individual. The initial result can be experienced as soon as within 24 hours to a few weeks upon infusion.

A: The effectiveness varies depending on the overall health and condition of the individual. In general, the MSC therapy is estimated to be effective between 8 months to as long as 24 months.

Redefine Your Health Journey with Safemed Innovations

At Safemed Innovations, in partnership with BioV Global Berhad we are more than just a biotechnology company- we are pioneers in regenerative medicine.

Our state-of-the-art Cellular Program, built on next-generation stem cell technology, is designed to provide safe, effective, and transformative treatments that redefine aging and promote health-span. With a focus on precision, innovation, and efficacy, we are dedicated to improving your health and wellness.